title: Immunotherapy-based regimen in anti-MAG neuropathy: results in 45 patients.
authors: marieannehospital@yahoo.fr.
authors: Marie-Anne
authors: MA
authors: Hospital
authors: Karine
authors: K
authors: Viala
authors: Sonia
authors: S
authors: Dragomir
authors: Vincent
authors: V
authors: Levy
authors: Fleur
authors: F
authors: Cohen-Aubart
authors: Jean
authors: J
authors: Neil
authors: Lucile
authors: L
authors: Musset
authors: Sylvain
authors: S
authors: Choquet
authors: Jean-Marc
authors: JM
authors: Leger
authors: Véronique
authors: V
authors: Leblond
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D018992:Myelin-Associated Glycoprotein / Q000037:antagonists & inhibitors* / Q000276:immunology*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000188:drug therapy* / Q000276:immunology*; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C115082:MAG protein, human; D018992:Myelin-Associated Glycoprotein; D000069283:Rituximab; D003520:Cyclophosphamide
keywords: IgM-monoclonal gammopathy; Waldenstrom’s macroglobulinemia; neuropathy; unknown significance